Cargando…
DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling
Dendritic cell immunoreceptor (DCIR) is an inhibitory C-type lectin receptor that acts as a negative regulator in the immune system and bone metabolism. We previously revealed that DCIR deficiency enhanced osteoclastogenesis and antigen presentation of dendritic cells, and that asialo-biantennary N-...
Autores principales: | Kaifu, Tomonori, Maruhashi, Takumi, Chung, Soo-Hyun, Shimizu, Kenji, Nakamura, Akira, Iwakura, Yoichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230091/ https://www.ncbi.nlm.nih.gov/pubmed/37266426 http://dx.doi.org/10.3389/fimmu.2023.1159058 |
Ejemplares similares
-
DCIR in the “osteo-immune” system
por: Maruhashi, Takumi, et al.
Publicado: (2015) -
DCIR and its ligand asialo-biantennary N-glycan regulate DC function and osteoclastogenesis
por: Kaifu, Tomonori, et al.
Publicado: (2021) -
Exacerbation of experimental autoimmune encephalomyelitis in mice deficient
for DCIR, an inhibitory C-type lectin receptor
por: SENO, Akimasa, et al.
Publicado: (2014) -
M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts
por: Hodge, Jason M., et al.
Publicado: (2011) -
Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023)